ONCOLOGY Harnessing the power of angiogenesis inhibitors The development of new blood vessels, known as angiogenesis, is critical for processes such as wound healing, but is exploited by tumors to enable more robust growth. Therapeutics targeting tumor angiogenesis have long been heralded as one of the most promising strategies for limiting a tumor's nutrient supply and eventually shrinking it. However, several recent preclinical trials have demonstrated that blocking angiogenesis in tumors can actually enhance invasion and metastasis...
More...
More...